Both Prkar2a−/− and Prkar2a+/− mice frequently developed hematopoietic neoplasms dominated by histiocytic sarcomas (HS) with rare diffuse large B cell lymphomas (DLBCL). This evidence concerns the gene PRKAR2A and hematopoietic and lymphoid cell neoplasm.